Posttranslational modification-oligomerization, phosphorylation, and proteolytic cleavage-of the human papillomavirus (HPV) E4 protein occurs as the infected keratinocytes migrate up through the suprabasal wart layers. It has been postulated that these events modify E4 function during the virus life cycle. In HPV type 1 (HPV1)-induced warts, N-terminal sequences are progressively cleaved from the full-length E4 protein (E1 ∧ E4) of 17 kDa to produce a series of polypeptides of 16, 11 and 10 kDa. Here, we have shown that in human keratinocytes, a truncated protein (E4-16K), equivalent to the 16-kDa species, mediated a G 2 arrest in the cell cycle that was dependent on a threonine amino acid in a proline-rich domain of the protein. Reconstitution of cyclin B1 expression in E4-16K cells reversed the G 2 arrest. Expression of E4-16K also induced chromosomal rereplication, and this was associated with aberrant nuclear morphology. Perturbation of the mitotic cell cycle was a biological activity specific to the truncated protein. However, coexpression of the full-length E1 ∧ E4 protein and the truncated E4-16K protein inhibited normal cellular proliferation and cellular DNA rereplication but did not prevent cells from arresting in G 2 . Our findings provide the first evidence to support the hypothesis that proteolytic cleavage of the E1 ∧ E4 protein modifies its function. Also, different forms of the HPV1 E4 protein cooperate to negatively influence keratinocyte proliferation. We predict that these distinct biological activities of E4 act to support efficient amplification of the viral genome in suprabasal keratinocytes.
Human papillomaviruses (HPVs) are a large group (Ͼ200 types) of small DNA viruses that infect cutaneous and mucosal squamous epithelium at a variety of anatomical sites. While the majority of HPV types induce benign hyperproliferative lesions that eventually regress, a small number of virus types can induce the malignant transformation of infected tissue (for a review, see reference 14) .
The complete replicative cycle of HPVs is tightly linked to the terminal differentiation program of the keratinocyte. Viral DNA maintenance and replication occur along with cellular chromosomal replication in proliferating basal cells, ensuring that both parent and daughter cells maintain a constant number of viral genomes. As cells migrate up through the epithelium, they undergo a complex pattern of differentiation. Concomitant with cellular differentiation in virally infected cells are the vegetative amplification of the viral genome, the expression of virus capsid proteins (L1 and L2), and finally the assembly of progeny virus. The HPV E4 protein is detected in productively infected cells. The E4 protein is translated from a spliced E1 ∧ E4 transcript to form an E1 ∧ E4 fusion protein that contains the first five amino acids from the E1 protein and almost the entire product of the E4 open reading frame (ORF). Several viral polycistronic mRNA transcripts contain the E1 ∧ E4 gene. The most abundant class (E1 ∧ E4 and E5) has been described for cutaneous and muscosal HPV types and is derived from a differentiation-inducible promoter in the E7 ORF (8, 16, 17, 24, 25, 39) . The other major E1 ∧ E4-containing messages derived from this promoter have the potential to also express the L1 and L2 capsid proteins (5, 18, 25) . Induction of E4 protein expression coincides with HPV DNA amplification, and the viral protein persists in cells expressing the capsid proteins and those producing newly synthesized virions (4, 10, 28) . The pattern of E4 distribution suggests that E4 function might be required at all stages of the productive cycle. Indeed, cottontail rabbit papillomavirus (CRPV) induced by CRPV mutant genomes that cannot express E4 fail to show evidence of productive viral events such as viral genome amplification or expression of the major capsid protein (27) .
In human warts and in in vitro cell culture systems that recapitulate the HPV life cycle, E4 exists as multiple species that are formed through a combination of proteolysis, oligomerization, and phosphorylation (for a review of E4 protein modification, see reference 32 and references therein). Studies, largely of the HPV type 1 (HPV1) E4 protein, have shown that the nature of these modifications is progressively altered as the infected cells migrate upwards within the infected tissue (4, 11, 15) . Therefore, although the role of E4 in the virus life cycle has not been elucidated, such posttranslational events might modify E4 function during the different stages of the productive phase of the life cycle.
Proteolysis of the mature HPV1 E1 ∧ E4 molecule involves the progressive cleavage of N-terminal residues (11) . Limited proteolysis of the E1 ∧ E4 17-kDa polypeptide removes the Nterminal 15 amino acids to tyrosine 16 to form a 16-kDa species (33) . Further proteolysis generates the 10-and 11-kDa proteins, with alanine 59 as the N-terminal residue (33) . In HPV1 warts, the 17-kDa polypeptide appears in the parabasal cells coincident with the onset of viral genome amplification ( Fig. 1) . The 16-, 11-, and 10-kDa polypeptides accumulate in a progressive manner, with the more processed forms becoming abundant in superficial keratinocytes, where capsid protein expression and the assembly of virus particles occur ( Fig. 1 ).
Recombinant molecules that closely resemble the 16-and 11-kDa processed forms do not colocalize with keratin intermediate filaments (33) , nor do they induce reorganization of nuclear dot 10 (ND10) domains (36) . Extreme N-terminal sequences of E1 ∧ E4 appear to be critical for these activities, such as the LLXLL motif ( 10 LLGLL 14 ) that is necessary for coalignment with the keratin cytoskeleton (33) . We would, therefore, predict that loss of N-terminal amino acids through proteolytic cleavage during the virus life cycle would eliminate those E4 functions dependent on sequences in the N-terminal domain (33) . An important question is whether the smaller forms of the E4 protein are functional proteins, and, if so, what role they play in the virus life cycle. Therefore, in this study we have investigated whether truncated HPV1 E4 proteins that closely resemble the naturally occurring processed proteins encode biological activities. We show that in immortalized and HPVtransformed human keratinocytes, a truncated E4 protein, equivalent to the 16-kDa species, can mediate a G 2 arrest in the cell cycle and that this arrest is reversed by exogenous expression of cyclin B1. Cells expressing the truncated protein also undergo rereplication of the cellular genome, and this is associated with aberrant nuclear morphology. Perturbation of cell division is specific to the truncated form of E4 and is not mediated by the full-length E1 ∧ E4 protein. Surprisingly, cells coexpressing the full-length and truncated E4 proteins do not show evidence of the rereplication of cellular DNA or aberrant mitotic division, despite retaining the ability to arrest in G 2 . Furthermore, coexpression is also associated with a significant inhibition of cellular proliferation. We predict that these biological activities of E4 act to support efficient amplification of the viral genome in differentiating keratinocytes.
MATERIALS AND METHODS
Cell culture. SCC-12F keratinocytes were grown in a 3:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium supplemented with 5% fetal calf serum, 2 mM glutamine, hydrocortisone (0.4 g ml Ϫ1 ), and antibiotics. SV-JD keratinocytes (simian virus 40 [SV40]-immortalized human epidermal keratinocytes) were maintained in culture as described previously (34) . The cervical tumor cell line HeLa and the epithelial cell line COS-1 were cultured as described for SV-JD keratinocytes. G418-resistant NIH 3T3 mouse fibroblasts were maintained in Dulbecco's modified Eagle's medium supplemented with 10% bovine serum, 2 mM glutamine, and antibiotics. For preparation of the NIH 3T3 fibroblasts for the feeder layer, cells were treated with 4,000 Rads of ␥ radiation.
Plasmid constructs and transfections. The construction of plasmids pcDNA-1E4 (E4-17K), pcDNA-1⌬2-15 (E4-16K), and pcDNA-1⌬2-58 (E4-11K) was described previously (36) .Plasmid pcDNA-1⌬2-15/Hyg was constructed by inserting the 1E4⌬2-15 cDNA into the BamHI site of the pcDNA3.1 vector containing the hygromycin B resistance gene (Invitrogen Life Technologies). The panel of E4-16K deletion mutations was PCR amplified from E4-17K mutant plasmids containing the amino acid deletions ⌬21-24, ⌬24-27, ⌬27-30, ⌬44-48, and ⌬49-53 (38) by using a forward primer (5Ј-GATGATAAGATCTATGTA CACTCCGACTACCCAA-3Ј) that deletes the DNA sequence coding for Nterminal residues 2 to 15 and a reverse primer (5Ј-GATATGAGATCTTTACA CAGACCACGGGT-3Ј) that reconstructs the C terminus of the E4 protein. PCR products were cloned by TOPO TA cloning (Invitrogen Life Technologies) into the expression vector pcDNA 3.1. The deleted amino acids correspond to the following HPV1 E4-16K sequences: ⌬7-10, ⌬10-13, ⌬13-16, ⌬30-34, and ⌬35-39. The QuikChange site-directed mutagenesis kit (Stratagene) was used to generate the alanine substitutions of Thr 13 , Pro 14 , Pro 15 , and Ser 16 . The primers used were 5Ј-CTATCCGAGAGTGGCACCGCCCAGCAATCGAC-3Ј (T13A), 5Ј-CTATCCGAGAGTGACAGCGCCCAGCAATCGACGTC-3Ј (P14A), 5Ј-GAGA GTGACACCGGCCAGCAATCGACGTCCATC-3Ј (P15A), and 5Ј-AGTGACACC GCCCGCCAATCGACGTC-3Ј (S16A). Bi-directional sequencing with an ABI Prism 3100 genetic analyzer was used to verify the sequences of all mutated plasmids. The cyclin B1-green fluorescent protein (GFP) expression plasmid, pcDNA3/cyclin B1-GFP was a generous gift from Jonathan Pines (Wellcome/Cancer Research UK Institute, Cambridge, United Kingdom).
For colony formation assays, subconfluent cultures of SCC-12F and HeLa keratinocytes were harvested by trypsinization, and 2 ϫ 10 6 cells were electroporated in the presence of 10 g of plasmid DNA by using 120 F/0.45 kV (Gene Pulser II; Bio-Rad). After 10 min on ice, the cells were transferred to 10 ml of normal growth medium and plated out into 10 6-cm dishes. To each dish of electroporated SCC-12F cells, 2 ϫ10
5 irradiated NIH 3T3 fibroblasts were added as a feeder layer. Transfected cells were selected by the addition of 400 g of G418 sulfate (Invitrogen Life Technologies) per ml and/or 200 g of hygromycin B (Sigma Chemicals) per ml; after 4 to 5 weeks of selection, they were fixed with 70% ethanol, and colonies were stained with 5% (wt/vol) Giemsa stain. Control dishes of mock-transfected cells were selected by using the same conditions; complete cell death was noted within the first week of selection, and no drugresistant colonies were formed.
To establish transient expression, 5 ϫ 10 5 cells were seeded into 6-cm dishes. The following day, cells were transfected with between 4 and 5 g of plasmid DNA by using the Lipofectamine Plus or Lipofectamine 2000 reagent (Invitrogen Life Technologies). Cells were harvested at various times posttransfection either for Western blot analysis or for cell cycle analysis.
Construction and infection of rAd. Recombinant adenoviruses (rAds) expressing the HPV1 E1
∧ E4 protein (Ad-1E4), the truncated protein E4-16K (Ad-1E4⌬2-15), and ␤-galactosidase (Ad-␤Gal) have been described previously (36) . Cells grown in dishes or on glass slides were infected with the rAds at a multi- Flow cytometric analysis. For DNA cell cycle analyses, cell pellets were resuspended in 70% ethanol and fixed at Ϫ20°C for 1 h. Cells were then pelleted by centrifugation and washed twice with phosphate-buffered saline (PBS). After the second wash, 1 ml of PBS containing 10 g of RNase (Sigma Chemicals) per ml was added, and the samples were incubated at 37°C for 1 h. The cells were pelleted by centrifugation and resuspended in 500 l of PBS containing 20 g of propidium iodide (PI) per ml. The relative cellular DNA content of stained cells was measured by using an EPICS XL flow cytometer (Coulter Electronics, Luton, United Kingdom). PI fluorescence was collected by using a 488-nm long-pass filter, followed by a 635-nm band-pass filter. Single cells were selected for analysis by using the distribution of PI fluorescence signal integral against PI fluorescence signal peak to discriminate doublets and debris. The relative size of PI fluorescence signal integral (DNA content) in single cells was plotted as a frequency histogram. Equal numbers of cells (10,000) were analyzed by fluorescence-activated cell sorting. The proportions of cells in phases G 0 /G 1 , S, and G 2 /M were deconvoluted from the latter by using Multicycle dedicated cell cycle analysis software (Phoenix Flow Systems, San Diego, Calif.).
For the analysis of cell cycle profiles of cells labeled with 5-bromodeoxyuridine (BrdU), rAd-infected or plasmid-transfected cells were incubated at various times after infection or transfection with 33 M of BrdU (Sigma Chemicals) for 2 h. The cells were harvested by trypsinization and pelleted by centrifugation. After fixation in 70% ethanol the samples were pelleted, washed twice in PBS, and treated with 1 ml of 2 M HCl at room temperature for 30 min. The samples were then washed twice in PBS and incubated at 37°C for 30 min in 500 l of PBS containing 0.5% Tween 20, 0.5% bovine serum albumin, and 0.5 g of fluorescein isothiocyanate-conjugated anti-BrdU monoclonal antibody (MAb; BD Biosciences, San Jose, Calif.). PI was added at a concentration of 5 g ml Ϫ1 and incubated at room temperature for 15 min prior to dual-parameter flow cytometric analysis to detect PI and fluorescein isothiocyanate staining for nuclear DNA and BrdU content. Two-dimensional profiles were analyzed by using Win MDI 2.8 (version 1.0; Purdue University Cytometry Laboratories).
Nocodazole synchronization. HeLa cells were infected with rAds, and after 48 h were treated with 10 M nocodazole (Sigma Chemicals) for 16 h. The mitotic-arrested cells were removed from the cell monolayer by vigorous washing with culture medium and were pelleted and resuspended in 1 ml of culture medium. Aliquots of 100 l were allowed to settle onto glass slides for approximately 3 h and then were processed for immunofluorescence analysis. Cells were incubated with appropriate primary and secondary antibodies, and DNA was visualized with 4,6-diamidino-2-phenylindole (DAPI; Sigma Chemicals).
Statistical analysis. Each experiment was performed at least three times. Statistical analysis of data was performed by using single-factor analysis of variance against the control plasmid pcDNA3.1.
Immunofluorescence microscopy and Western blotting. Cells grown on glass slides were fixed in 4% (wt/vol) paraformaldehyde in PBS for 5 min and permeabilized in acetone at Ϫ20°C for 10 min. Immunofluorescence staining was performed as described elsewhere (36) . E4 proteins were detected by using the MAb 4.37 (1/250 dilution) (11) . An MAb against ␤-galactosidase (1/400 dilution) was purchased from Promega (Madison, Wis.). MAbs specific for cyclin A and cyclin B1 were obtained from Santa Cruz Technologies and Upstate Technology, respectively. Both were used at a 1/50 dilution. Immune complexes were visualized by using AlexaFluor 488-labeled anti-mouse specific antibody conjugate (Molecular Probes), and nuclei were counterstained with DAPI. Immunofluorescence was observed by using a Nikon Eclipse E600 microscope with appropriate filter sets, and images were captured by using a Leica DC200 digital camera. Images were assembled in Adobe Photoshop 6.0.
For Western blotting, cells were lysed in 8 M urea, 25 mM Tris (pH 8.0), 0.15 M ␤-mercaptoethanol, 10 g of leupeptin per ml, and 10 g of pepstatin per ml. After sonication insoluble material was removed by high-speed centrifugation. Equal amounts of protein were electrophoresed on sodium dodecyl sulfatepolyacrylamide (10 to 12% acrylamide) gels. Separated proteins were transferred to a nitrocellulose membrane, and Western blotting was performed with the following primary antibodies: MAb 4.37 (HPV1 E4 proteins) and the anti-␤-galactosidase MAb (1/1000 dilution). To control for loading, actin levels were determined by using an anti-␤-actin MAb (1/40,000 dilution; Sigma Chemicals). Primary antibodies were detected with horseradish peroxidase-labeled antimouse immunoglobulins (Sigma Chemicals), and membranes were subjected to chemiluminescence detection (ECL; Amersham Pharmacia).
RESULTS

Loss of N-terminal residues from the HPV1 E1
∧ E4 protein is associated with suppression of keratinocyte growth. In previous studies, we had noted that keratinocytes were unable to support the stable expression of HPV E4 proteins, suggesting that these viral proteins can interfere with normal cell growth (reference 34 and unpublished data). To investigate these observations in detail, we assessed the consequence of expression of the full-length HPV1 E1 ∧ E4 polypeptide (17 kDa) on keratinocyte growth and also that of two N-terminal deletion proteins ⌬2-15 and ⌬2-58 ( Fig. 2A ). These two truncated proteins closely resemble the 16-and 11-kDa E4 polypeptides expressed in HPV1-induced warts, except that they have an N-terminal initiation methionine (33) . We will refer to the full-length E1 ∧ E4 protein as E4-17K, to ⌬2-15 as E4-16K, and to ⌬2-58 as E4-11K. Plasmids that express the different E4 polypeptides were transfected into SCC-12F keratinocytes.
The SCC-12F cell line is an immortalized but nontumorigenic cell line derived from stratified squamous epithelium, and the cells behave like primary keratinocytes in vitro (26, 31) . The E4 expression plasmids also express the antibiotic G418 resistance marker. After a 4-week selection by G418 sulfate, we observed that in comparison to the control (empty pcDNA3.1 vector), transfection of SCC-12F cells with the E4-16K-coding plasmid leads to a significant decrease in the number (38.5%) and size (55.5%) of colonies ( Fig. 2B ). There was no significant change, however, in the number or size of colonies generated following transfection with the E4-17K-expressing plasmid and only a slight reduction in colony number and size with the E4-11K expressing plasmid (Fig. 2B) . No drug-resistant colonies were formed in mock-transfected cells. Similar results were obtained in HPV18-positive HeLa cervical tumor keratinocytes electroporated with the E4 expression plasmids (see Fig. 6A ). Analysis of the clones for E4 expression at the end of the selection period showed that none had retained expression of any of the three transgenes, which is consistent with previous findings (reference 34 and our unpublished data). We also examined the effect of the HPV1 E4 polypeptides on short-term keratinocyte growth. SCC-12F cells were infected with rAds that express E4-17K, E4-16K, or ␤-galactosidase, and cells were counted over a period of 5 days (Fig. 2C) . Cell cultures expressing the E4-16K protein grew significantly more slowly than either mock-infected cells or cultures infected with the ␤-galactosidase-expressing virus. SCC-12F growth was also repressed by E4-17K protein, although not to the same extent as observed with the truncated polypeptide (Fig. 2C ). Similar findings were obtained following infection of SV40-immortalized human epidermal keratinocytes (SV-JD) (Fig. 2C) . Immunofluorescence microscopy and Western blotting confirmed that the frequency of infection with the different rAds was similar and that ␤-galactosidase and E4 protein levels were comparable (data not shown). We did note that in cells infected with the rAd expressing E4-17K, there was a progressive accumulation of the truncated 16-kDa polypeptide, an observation that is consistent with previous findings (34, 35) . Therefore, repression of keratinocyte growth in E4-17K-ex-pressing cells might reflect an accumulation of the truncated 16-kDa species. Collectively, these data suggest that a loss of extreme N-terminal amino acids from the full-length HPV1 E1 ∧ E4 polypeptide is associated with suppression of the growth of immortalized human keratinocytes. E4-16K induces an arrest in the G 2 phase of the cell cycle. Repression of cell growth by E4-16K, and also to some extent E4-17K, might reflect an arrest of the cells at a defined point in the cell cycle. To investigate this possibility, SCC-12F cells were infected with the different rAds, and cell cycle profiles were determined at different times postinfection (p. i.) by flow cytometry analysis (Fig. 3A) . Infection with the virus expressing E4-17K or the control virus expressing ␤-galactosidase produced cell cycle profiles that were similar to those of mockinfected cells, and there was no significant change in the G 2 ϩM:G 1 ratios, even at late times after infection. However, expression of the truncated E4-16K protein induced a marked increase in the G 2 /M population, which was evident between 48 and 72 h p. i. The ability of E4-16K to induce G 2 /M arrest was also evident in HeLa cells, occurring as early as 24 h after infection (Fig. 3A) , and also in COS-1 cells transfected with E4 expression plasmids (Table 1) . Western blot analysis showed protein to induce cell cycle arrest was not due to protein instability ( Fig. 3B and data not shown).
Since single-parameter DNA histograms cannot discriminate G 2 from M-phase cells, we used the microtubule disrupter nocodazole, which interferes with the formation of the mitotic spindle, to determine at what stage in the progression of cells through G 2 and into mitosis the E4-16K-expressing cells were arrested. HeLa cells were infected with the different rAds and treated with nocodazole at 48 h p. i. to induce mitotic arrest. Isolated mitotic cells expressing ␤-galactosidase and E4 proteins were identified by immunofluorescence microscopy. As shown in Fig. 3C , 97.0 and 61.5% of mitotic cells were expressing ␤-galactosidase and the full-length E4-17K proteins, respectively. In contrast, only 3.4% of cells arrested in mitosis were E4-16K positive. The higher mitotic index for ␤-galactosidase cells (compared to E4-17K cells) was most likely because this virus had a greater efficiency of infection (as inferred from immunofluorescence staining) than the two E4 rAds, which were equivalent to each other. We therefore conclude that E4-16K induces cells to arrest in the G 2 phase of the cell cycle (with a DNA content of 4N) and not in mitosis.
A proline-rich sequence in E4-16K is necessary for G 2 cell cycle arrest. Next, we wanted to identify which E4 sequences were mediating the G 2 arrest. At this point in our investigation, two studies were published demonstrating that full-length E1 ∧ E4 proteins from two oncogenic HPV types, 16 and 18, induced a G 2 arrest of HeLa cervical keratinocytes (9, 23) . The ability of these proteins to induce cell cycle arrest was mapped to a proline-rich sequence that lies close to the N terminus of the E1 ∧ E4 protein (9) . A similar region of the HPV1 E1 ∧ E4
protein is also rich in proline amino acids (33) and is retained in the E4-16K protein ( Fig. 2A) . To test whether this region is required for the G 2 arrest function of E4-16K, we generated a small set of E4-16K mutants containing deletions across part of the proline-rich region and across a neighboring region that is rich in charged residues (Fig. 4A) . Because the efficiency of transfection into SCC-12F cells is very poor (Ͻ5%), we transfected the plasmids expressing the E4 mutants into HeLa cells (Fig. 4B) . Two of the three mutant 16K proteins containing deletions of proline-rich sequences, 16K⌬10-13 and 16K⌬13-16, did not induce an arrest. The third mutant, 16K⌬7-10, did induce a significant accumulation of cells in G 2 /M although the level of the cell cycle block was slightly less than observed with E4-16K. Deletion of charged residues (30 to 34 and 35 to 39) had no significant effect on E4-16K-induced cell cycle arrest. All E4 proteins with the exception of 16K⌬35-39 were expressed at equivalent levels (Fig. 4C) . Similar G 2 /M profiles occurred following transfection of the different plasmids into COS-1 epithelial cells (data not shown).
We conclude that a proline-rich sequence, 10 PRVTPPS 16 , (equivalent to positions 24 to 30 in the full-length E1
∧ E4 sequence [33] ) is necessary for E4-16K-mediated G 2 arrest of human keratinocytes.
The PRVTPPS sequence contains a threonine (Thr 13 ) and serine residue (Ser 16 ). Threonine and serine residues in the HPV1 E4 protein are known to be substrates for several different protein kinases (15) , and phosphorylation of such residues might be necessary for HPV16 E1
∧ E4-induced cell cycle block (9) . In order to determine whether Thr 13 and Ser 16 are required for the activity of the E4-16K protein, they were mutated to alanine residues by site-directed mutagenesis. Two out of the three proline residues (Pro 14 and Pro 15 ) were also replaced by alanines. With the exception of the mutant E4-16KT13A, expression of the other mutant proteins (E4-16KP14A, E4-16KP15A, and E4-16KS16A) induced an increase in the G 2 /M population in HeLa cells, comparable with that observed for the wild type E4-16K protein (Fig. 5A) . In contrast, the cell cycle profile of E4-16KT13A-transfected cells was similar to the profile of cells expressing the full-length E4-17K protein (Fig. 5A) . Equivalent steady-state expression levels of all the E4 proteins were noted following Western blotting (Fig. 5B) . We therefore conclude that Thr 13 in the proline-rich sequence is required for the G 2 cell cycle arrest function of the E4-16K protein.
Exogenous expression of cyclin B1 abolishes E4-16K induced G 2 arrest. The progression of cells from interphase into mitosis is regulated by cyclin-cyclin-dependent kinase (cdk) activity (for a review, see reference 30). Commitment to cell division is mediated by activation of the cyclin B1-cdk1 complex, the core component of the mitosis-promoting factor. Cyclin B1-cdk1 activity is regulated, in part, by the accumulation of cyclin B1 during G 2 /M and its translocation from the cytoplasm to the nucleus (29) . Failure of E4-16K cells to progress into mitosis might, therefore, be due to an aberration in the pathways that regulate cyclin B1-cdk1 activity. In the first instance we examined whether exogenous expression of cyclin B1 would enable E4-16K-expressing cells to progress through the cell cycle. In order to obtain sufficient levels of cotransfection of the expression plasmids, we used COS-1 epithelial cells. Cells were cotransfected with the E4-16K plasmid and a plasmid that expresses cyclin B1-GFP from the cytomegalovirus promoter (a kind gift from Jonathan Pines) and analyzed at 48 h posttransfection. Table 1 shows the mean percentage of Table 1) . Expression of cyclin B1-GFP and E4 proteins was confirmed by immunofluorescence microscopy (data not shown). Our data suggest that exogenous expression of cyclin B1 can overcome E4-16K-induced G 2 arrest of COS-1 epithelial cells. In colony formation assays, E4-16K expression repressed the growth of SCC-12F keratinocytes (Fig. 2B) . We would predict from our studies that the G 2 arrest function of E4-16K mediates the suppression of colony growth. Furthermore, if cyclin B1 expression can rescue the cell cycle progression of E4-16K cells, then coexpression of the two proteins should restore colony formation. To test this hypothesis, we cotransfected HeLa cells with the cyclin B1-GFP plasmid, which contains the neomycin selectable marker and an E4-16K expression plasmid (pcDNA-1⌬2-15/Hyg) that carries the hygromycin B resistance gene, and selected for colonies by using G418 and hygromycin B. Also, cells were transfected with the cyclin B1 plasmid alone and the different E4 expression plasmids, including the G 2 arrest-defective E4-16K mutant lacking the sequence TPPS (E4-16K⌬13-16 ). Expression of E4-16K caused a marked decrease in colony formation compared to cells transfected with E4-17K or the empty vector (Fig. 6A ) and supports our findings derived from SCC-12F cells (Fig. 2B) . In contrast, expression of E4-16K⌬13-16 that is unable to induce G 2 arrest did not repress colony formation (Fig. 6A) . Furthermore, the inhibitory effect of wild-type E4-16K was reversed upon cotransfection of cyclin B1 (Fig. 6A) . Taken together, our results show that the G 2 arrest function of E4-16K mediates the suppression of keratinocyte growth and that this function of E4-16K is overcome by exogenous expression of cyclin B1.
Immunofluorescence microscopy was used to assess whether E4-16K alters cyclin B1 protein expression or subcellular distribution. SCC-12F cells were infected with the different rAds, and at 96 h p. i. cells were stained for both cyclin B1 and E4 or ␤-galactosidase. As a control we also stained cells with an anti-cyclin A antibody. Flow cytometry of parallel cultures was used to confirm a G 2 /M arrest in the AdE4-16K-infected cells. Fifteen percent of E4-17K-positive cells were cyclin B1 positive, and this percentage was comparable to the proportion of ␤-galactosidase-expressing cells (Fig. 6B) . In contrast, only 3.5% of E4-16K cells expressed cyclin B1 (Fig. 6B) . This result was unexpected as cyclin B1 levels normally accumulate during G 2 /M (30), and, therefore, we would expect a majority of E4-16K cells to be expressing significant levels of cyclin B1. To exclude the possibility that the epitope recognized by the cyclin B1 MAb is masked in E4-16K cells, we used a cyclin B1 polyclonal antibody and obtained a similar decrease (ϳ70%) in cyclin B1-positive E4-16K cells (data not shown). In E4-16K cells that were cyclin B1 positive, cyclin B1 was predominantly nuclear, and there was no coincidence between the two proteins (data not shown). Cyclin A levels also increase in G 2 , and cyclin A is degraded by the anaphase promoting complex\cyclosome prior to cyclin B1. The number of cells expressing both E4-16K and cyclin A had increased compared to the controls, which is consistent with a G 2 arrest (Fig. 6B,  panel a) , and indicates that the decrease in detection of cyclin B1 is specific.
E4-16K induces rereplication of the cellular genome. Analysis of the cell cycle profiles of E4-expressing SCC-12F and HeLa cells showed that in AdE4-16K-infected cells there was, in addition to a G 2 cell cycle block, also a consistent accumulation of cells with a DNA content of greater than 4N (8N and 16N populations are indicated by arrows in Fig. 3A) . Although there was evidence that mock-infected cells and cells infected with rAds expressing E4-17K and ␤-galactosidase also had a population of Ͼ4N cells, these were at a level consistently lower than the levels observed in AdE4-16K-infected cultures (Fig. 3A) . This result suggested that a portion of AdE4-16K-infected cells were continuing to replicate their DNA without completing cell division. Microscopical examination of rAdinfected SCC-12F and HeLa cells showed that a greater pro- portion of E4-16K-expressing cells contained large and often distorted nuclei than those expressing E4-17K or ␤-galactosidase (Fig. 7A, panels a and b, and data not shown) . Notably, at later times p. i. (SCC-12F, Ͼ96 h; HeLa, Ͼ24 h) there was a marked induction of E4-16K cells with multiple nuclei (Fig.  7A , frames c and d, and B; also data not shown). We also noted that the E4-16K protein was both cytoplasmic and nuclear in cells with aberrant and multiple nuclei (Fig. 7A, a and c) , while in cells with normal nuclear morphology, the protein is predominantly found in the nucleus (Fig. 6B, b ) (see references 33 and 36) .
To establish whether the G 2 arrest function of E4-16K was associated with multinucleation, E4-16K mutant plasmids were transfected into HeLa cells, and the percentage of multinucleate E4-positive cells was determined at 48 h by immunofluorescence microscopy (Fig. 7C) . While the numbers of multinucleate cells in cultures transfected with the empty vector control or E4-17 were equivalent, there was a 3.5-fold increase in E4-16K-positive multinucleate cells (Fig. 7C) , findings that are in agreement with data from rAd-infected cells (Fig. 7B) . The mutant proteins defective in G 2 arrest induction (E4-16K⌬10-13 and E4-16K⌬13-16) failed to induce a significant increase in multinucleate cells (Fig. 7C) , indicating that the sequence 10 PRVTPPS 16 is necessary for cell cycle arrest and aberrant cell division.
It was also possible to detect the population of rereplicating cells following incubation in the presence of BrdU, a thymidine analogue that is incorporated into cells undergoing DNA synthesis. HeLa cells were transiently transfected for 48 h with the empty vector or the plasmids encoding E4-17K and E4-16K and then pulse-labeled with BrdU for 2 h. Two-dimensional flow cytometry showed that BrdU incorporation into cells with a DNA content of Ͼ4N increased by between 2.1-and 4.0-fold in E4-16K-expressing cultures, compared to cells transfected with the empty vector and pcDNA1-E4 (E4-17K), respectively (Fig. 7D, a) . Analysis of mutant proteins 16K-T13A, 16K-P14A, 16K-P15A, and 16K-S16A demonstrated that only the G 2 -defective mutant 16K-T13A failed to induce an increase in Ͼ4N cells (Fig. 7D, b) . Because rereplication of the cellular genome does not occur in cells incapable of G 2 arrest, this suggests that after arresting in G 2 , E4-16K cells eventually reenter the cycle and undergo additional rounds of DNA replication. This scenario would be consistent with the appearance of E4-16K-expressing cells with enlarged nuclei. The formation of cells containing multiple nuclei suggests that a population of (Fig. 1) , we wanted to determine whether the E4-16K could still induce cell cycle arrest in the presence of the full-length protein. SCC-12F keratinocytes coinfected with rAds expressing E4-17K and E4-16K for 72 h showed a marked increase in the G 2 /M population, equivalent to the level observed in AdE4-16K-expressing cells (Fig. 8A) . Western blot analysis of lysates prepared from these cultures demonstrated that in dual-infected cells, the E4-17K and E4-16K proteins were expressed in similar amounts as in cultures infected with the individual viruses (Fig. 8B) . It would seem, therefore, that E4-16K is able to induce a G 2 arrest in the presence of the E1 ∧ E4 protein. In Ad-E4-17K-infected cells, a small amount of E4-17K is processed to 16 kDa (34), but the level is insufficient to interfere with cell cycle progression. Next, we examined whether E4-17K influenced E4-16K-induced aberrant cell division. Immunofluorescence analysis showed that in contrast to cells infected with the AdE4-16K virus, there was no increase in the number of E4-positive multinucleate cells in dual-infected SCC-12F cells compared to controls (data not shown). A decrease in the Ͼ4N population was also apparent following BrdU-labeling of infected cultures (Fig. 8C) . The level of BrdU-positive cells with a DNA content of Ͼ4N decreased from nearly 30.0% in AdE4-16K-infected cells to 19.0% in the dual-infected cultures, a level similar to that observed in the controls. The level of Ͼ4N BrdU-positive cells remained high (25.88%) following coinfection with AdE4-16K and Ad-␤Gal, indicating that a negative effect on E4-16K-induced chromosomal rereplication is mediated specifically by the E1 ∧ E4 protein. Interestingly, further analysis of the flow cytometry profiles showed that in comparison to cells infected with the individual E4 viruses, coinfection also induced a marked reduction in BrdU incorporation into replicating diploid cells (Fig. 8C) . The number of cells in S phase decreased from nearly 39.0% in Ad-E416K-infected cells to ϳ13.0% in dual-infected cultures. A similar reduction was not apparent in cells expressing E4-17K alone (33.73%) or cultures coexpressing E4-16K and ␤-galactosidase (35.72%). Taken together, our data suggest that when expressed together, E4-17K and E4-16K can inhibit cellular proliferation. Consistent with these findings, we noted that in HeLa colony formation assays, compared to the empty vector control, E4-17K expression gave no significant reduction in colony formation, E4-16K expression induced an 83.6% reduction, and coexpression of E4-17K and E4-16K resulted in a 100% reduction of colony formation.
To determine whether E4-17K-induced repression of cellular DNA synthesis was dependent on the G 2 arrest function or a separate function of E4-16K, we proceeded to examine the effect of E4-17K on cellular DNA replication in the presence of the G 2 arrest-defective E4-16K mutant E4-16KT13A. COS-1 epithelial cells were transfected with plasmids coding for the different HPV1 E4 proteins and labeled with BrdU 36 h after transfection. The G 2 arrest function of E4-16K is active in COS-1 cells (Table 1) . The viral protein also induced a significant increase in the rereplicating population, and coexpression of E4-17K and E4-16K induced a reduction in this cell population (Fig. 8D, a) , consistent with the data obtained from rAd-infected SCC-12F keratinocytes. Furthermore, coexpression of the E4 proteins also mediated a marked decrease (2.6-fold) in BrdU incorporation into S phase nuclei compared to cells expressing E4-16K alone (Fig. 8D, b) . However, the decrease in BrdU incorporation was not apparent when E4-17K was expressed in the presence of the E4-16KT13A (Fig. 8D, b) , supporting the notion that the activity mediated by Thr 13 in E4-16K is necessary for E4-17K/16K inhibition of cellular DNA synthesis.
We therefore conclude that following coexpression of HPV1 E1 ∧ E4 and the truncated in vivo-like polypeptide E4-16K, the two proteins cooperate to negatively regulate the normal cell cycle progression of human keratinocytes.
DISCUSSION
This study presents the first evidence that a truncated in vivo-like protein of HPV1 E4 encodes biological functions that are distinct from those mediated by the full-length form. It supports the hypothesis that proteolytic processing of E4 modifies its biological function (33, 37) . We have shown that expression of an HPV1 E4 deletion protein (E4-16K) whose primary structure closely resembles the 16-kDa polypeptide expressed in vivo induced a G 2 arrest of human keratinocytes derived from squamous epithelia. The effect on the cell cycle was not dependent on the action of other HPV proteins. Continued high-level expression of the truncated protein gave rise to hyperploid cells, distinguished by large distorted nuclei, as well as cells containing multiple nuclei, indicating rereplication of the cellular genome and aberrant nuclear division. Intriguingly, the effect of E4-16K on cell division was partially altered upon coexpression of the full-length E1 ∧ E4 protein. While the G 2 arrest function was not affected, rereplication of the cellular genome and aberrant nuclear division were prevented. Moreover, coexpression of the two forms of E4 led to negative regulation of cellular proliferation. While this study was in progress, two groups published evidence that the full-length E1 ∧ E4 proteins of anogenital HPV types 16 and 18 induced a G 2 arrest of cervical carcinoma cells (9, 23) . Taken together with our findings, the data suggest that a G 2 arrest function appears to be an E4 activity conserved between unrelated HPV types; HPV1 has a tropism for cutaneous palmar and plantar epithelium. In our study, there was no evidence that the full-length E1 ∧ E4 protein had an effect on G 2 /M progression of keratinocytes. Thus, the G 2 arrest function is specific to the truncated HPV1 polypeptide. However, we cannot rule out the possibility that in natural HPV1 infections, E1 ∧ E4 does encode such a function and that it is dependent on a specific posttranslational event such as phosphorylation or interaction with cellular and/or viral factors that are not expressed in our culture systems. The cell cycle arrest functions of HPV1 E4-16K and HPV 16 E1 ∧ E4 are both dependent on a threonine residue contained within proline-rich domains. This suggests a common mechanism of action, perhaps one that involves phosphorylation of this residue (9 Normal G 2 /M transition is regulated by the activities of cyclin A-cdk1 and cyclin B1-cdk1 complexes (30) . We found that the G 2 arrest function of E4-16K correlated with its ability to suppress keratinocyte growth, and both growth suppression and G 2 arrest were reversed by reconstitution of cyclin B1 expression ( Fig. 6A and Table 1 ). Our results suggest that failure of E4-16K-expressing cells to transverse G 2 to M might be via a mechanism that prevents the formation of active cyclin B1-cdk1 complexes. Immunofluorescence studies showed that cyclin B1 protein was not detected in a majority of E4-16K G 2 -arrested cells, and this finding was in contrast to results of cyclin A staining (Fig. 6B) . Since the levels of both cyclin A and B1 proteins normally increase during G 2 /M, this result was somewhat surprising and therefore warrants further investigation. Because the decrease in cyclin B1 protein was apparent in E4-16K cells with single nuclei (Fig. 6B) and not in multinucleate cells (see below), the reduction in cyclin B1 cannot be a reflection of anaphase promoting complex\cyclosome-mediated degradation of cyclin B1 that would normally occur prior to sister chromatid separation (30) . It is, therefore, tempting to speculate that the failure of E4-16K cells to undergo G 2 /M transition might involve inhibition of cyclin B1 protein accumulation and/or an inappropriate loss. Interestingly, an unscheduled decrease in cyclin B1 levels is associated with G 2 /M arrest induced by the human T-lymphotropic virus type 1 Tax oncoprotein and the Epstein-Barr virus BZLF1 protein (20) (21) (22) .
Morphological changes (nuclear enlargement and multinucleation) and rereplication of the cellular genome were associated with the activity of Thr 13 in E4-16K function (Fig. 7 ). These observations suggest that after arresting in G 2 , E4-16K cells eventually reenter the cell cycle and undergo additional rounds of DNA replication, a scenario consistent with nuclear enlargement. Multinucleation indicates that some of these cells enter mitosis but are unable to complete cell division. Perhaps the decrease in cyclin B1 levels in E4-16K cells contributes to the process of rereplication of the cellular genome, as it is known that cyclin B1 or cdk1 activity is required to prevent chromosomal reduplication in the fission yeast Schizosaccharomyces pombe and Drosophila (38, 41) . Since aberrant nuclear morphology is also associated with expression of anogenital E1 ∧ E4 proteins (reference 23 and our unpublished data), perhaps E4 proteins can also interfere with cellular pathways that regulate mitotic progression and execution of cytokinesis. An interesting finding of this study was that coexpression of the full-length E1 ∧ E4 protein and the truncated E4-16K protein inhibited normal cellular proliferation and cellular DNA rereplication but did not prevent cells from arresting in G 2 (Fig. 8) . The inhibition of cellular DNA synthesis was not apparent upon expression of either protein independent of each other, suggesting that these two forms of the E4 protein are able to functionally cooperate to negatively influence cell proliferation. Moderate repression of short-term keratinocyte growth by E4-17K (Fig. 2C) probably reflects an accumulation of the truncated 16-kDa species, and subsequent cooperation between the two forms of E4. We are now in the process of elucidating the underlying molecular basis for the negative regulation of cellular proliferation by the HPV1 E4 protein.
One possible explanation is that the two proteins interact directly with one another to form an active complex (2, 13, 35) , mediated by sequences within the C termini of the proteins (2). This complex may be able to directly interfere with the process of cellular DNA synthesis. Alternatively, one of the E4 polypeptides might promote an interaction between the other HPV1 E4 protein analysis in serial sections of warts taken parallel to the skin showed that the truncated E4 polypeptides appear in a progressive manner, with the 16-kDa species accumulating prior to the 10-and 11-kDa polypeptides (4) (Fig.  1) . There was significant overlap between expression of the E1 ∧ E4 and 16-kDa polypeptides, and in some sections the two proteins were present in equivalent amounts. Only in the deepest suprabasal layers was E1 ∧ E4 protein detected by itself. In natural HPV1 infections, viral genome amplification initiates in cells that have moved up from the basal layer, and this correlates with the onset of E1 ∧ E4 expression (4, 12, 28) .
These cells are stimulated to remain in an S-phase-like state through the activities of E7 (6), enabling the virus access to the host cell's replication machinery. The ability of HPV1 E1 ∧ E4
protein to interact with cellular structures such as the keratin cytoskeleton and ND10 domains might facilitate the initial stage of the productive cycle, perhaps by organizing viral transcription and/or replication centers at E4-PML nuclear structures (34, 36) . As genome amplification proceeds, the G 2 arrest function of the truncated 16-kDa form might stimulate maintenance of the replication capacity of the differentiating keratinocyte by inhibition of further progression through the cell cycle. Continuous unscheduled host cell DNA synthesis (7), however, would present a drain on the nucleotide pool and on essential cellular replication factors that are also required by the virus for high-level replication of its own genome; HPV1 is a hugely efficient virus, producing as many as 10 12 virus particles in cutaneous verrucae (3) . Inhibition of host chromosome replication by E4 would enable cellular replication enzymes and nucleotides to be sequestered to viral DNA replication centers. Thus, the overall effect of E4 activity would be to keep infected keratinocytes in a metabolically active state without competing host DNA synthesis in order to maximize virus genome amplification. Such a scenario is not without precedent. Recent studies of herpesviruses (cytomegalovirus and Epstein-Barr virus) have shown that they have evolved mechanisms that allow activation of S-phase promoting cdk activity while cellular DNA synthesis is inhibited, presumably to support high-level viral DNA replication (19, 40) .
Evidence to support a role for HPV E4 as a major regulator of the productive phase of the virus life cycle has yet to be presented. However, loss of E4 protein in papillomas induced in rabbits following inoculation with mutant E4 knockout CRPV genomes has been shown to severely compromise efficient viral genome amplification in suprabasal keratinocytes of papillomas (27) . It was also noted that the E4 knockout genome was far more efficient at producing papillomas than the wild-type DNA, suggesting that CRPV E4 might negatively control CRPV DNA-containing keratinocyte proliferation. Thus, perhaps the ability to modify cell proliferation is a function conserved between E4 proteins of different virus types. This novel biological activity might be dependent on cooperation between different posttranslationally modified forms of the protein, as we have shown for HPV1 E4.
